Nabla Bio

About:

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

Website: https://www.nabla.bio

Top Investors: Khosla Ventures, National Science Foundation, Y Combinator, Radical Ventures, Cantos

Description:

Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.

Total Funding Amount:

$37.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-05-29

Contact Email:

http://founders(AT)nabla.bio

Founders:

Frances Anastassacos, Surge Biswas

Number of Employees:

11-50

Last Funding Date:

2024-05-14

IPO Status:

Private

© 2024 MyAiNote.com